Announced
Completed
Financials
Tags
Acquisition
medical devices development
Majority
Private
Completed
Private Equity
Friendly
United States
Medical Equipment
Single Bidder
Synopsis
Arlington Capital Partners, a Washington, DC-based private equity firm, has completed a majority growth investment in Riverpoint Medical, a developer, designer, and manufacturer of medical devices focused on advanced bio-medical textile technologies. Riverpoint's founders and senior management have all made substantial investments as part of the transaction and will continue to lead the company's strategic growth initiatives in the future. Matt Altman, a Managing Partner at Arlington, says: "Riverpoint's ability to develop innovative technologies coupled with its unique manufacturing processes provide a strong platform to accelerate growth in large addressable markets. Our investment in Riverpoint continues Arlington's history of building differentiated, high-growth medical device manufacturers in partnership with company founders and existing senior management."
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.